Thank you to the following AACE Corporate Association Partners who make Power of Prevention possible!
Novo Nordisk responded to AACE’s call for support in 2003 during the planning stages of Power of Prevention (POP). Novo Nordisk has continuously supported the POP program for the past five years through unrestricted educational grants.
Novo Nordisk is a world leader in diabetes care and other pharmaceutical products. Its North American headquarters in located in Princeton, New Jersey. Novo Nordisk has approximately 2,000 employees nationwide handling sales, marketing, managed care, trade and government activities. Other departments include medical, regulatory affairs and quality assurance, legal/patents, strategic business operations and human resources.
AACE would like to thank Novo Nordisk for their support in making this website possible.
Abbott Laboratories replied to AACE’s call to support the Power of Prevention Guide to Physical Activity. Abbott supported the creation, development, printing and distribution of the guide through an unrestricted educational grant.
Abbott is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Its products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Its comprehensive line of products encircles life itself – addressing important health needs from infancy to the golden years.
Eli Lilly & Company replied to AACE’s call to support the Power of Prevention Guide to Physical Activity. Eli Lilly & Company supported the creation, development, printing and distribution of the guide through an unrestricted educational grant.
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs.
Quest Diagnostics replied to AACE’s call to support the Power of Prevention Guide to Physical Activity. Quest Diagnostics supported the creation, development, printing and distribution of the guide through an unrestricted educational grant.
Quest Diagnostics is the nation's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Our customers and payers include patients, physicians, hospitals, health insurers, employers and government agencies.
In 2006, Genzyme responded to AACE's request for an educational/scientific grant in support of the development of the Power of Prevention Patient Website. Genzyme also made the Thyroid Cancer section of this website possible through an unrestricted educational grant.
Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $2 billion and more than 8,500 employees in locations spanning the globe. With many established products and services helping patients in more than 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences to address a range of unmet medical needs. The company’s products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant and immune disease, cancer, and diagnostic testing. Genzyme’s commitment to innovation continues today with a substantial research and development program focused on genetic diseases, immune system disorders, heart disease, and cancer.
